Osler Diagnostics is trying to change point-of-care diagnostics in the wake of the Theranos scandal.
The criminal trials Elizabeth Holmes and Sunny Balwani, Theranos' CEO and COO, respectively, have been as humorous as they have...
Is Osler Diagnostics The Next Theranos Or Can It Surprise Everyone?
Founded with a vision to change point-of-care diagnostics, Osler Diagnostics has raised nearly $200m to develop and commercialize a platform that promises to revolutionize diagnostics with just a drop of a patients’ blood.
